FrancophonIA/ELRC3.0 huggingface dataset:
English: After 12 weeks, it had fallen by around 6.4 points in the men who took Silodyx, and by around 3.5 points in the men who took placebo.
Estonian: Pärast 12nädalast ravi oli see Silodyxi võtnud meestel vähenenud 6,4 punkti võrra ja platseebot võtnud meestel 3,5 punkti võrra.
English: The prostate gland is an organ found at the base of the bladder in men.
Estonian: Eesnääre on organ, mis asub mehe kusepõie all.
English: Silodyx is not recommended for patients with severe kidney problems.
Estonian: Raskete neeruprobleemidega patsientidel ei soovitata Silodyxi kasutada.
English: What is Silodyx?
Estonian: Mis on Silodyx?
English: Why has Silodyx been approved?
Estonian: Miks Silodyx heaks kiideti?
English: One of these studies also compared Silodyx with tamsulosin (another medicine used for BPH).
Estonian: Ühes neist uuringutest võrreldi Silodyxi ka tamsulosiiniga (samuti eesnäärme healoomulise hüperplaasia ravim).
English: Silodyx was more effective than placebo and as effective as tamsulosin at reducing symptoms of BPH.
Estonian: Silodyx oli eesnäärme healoomulise hüperplaasia sümptomite vähendamisel efektiivsem kui platseebo ja sama efektiivne kui tamsulosiin.
English: By blocking these receptors, silodosin allows these muscles to relax, making it easier to pass urine and relieving the symptoms of BPH.
Estonian: Alfa-1A-adrenoretseptorite blokeerimisega lõõgastab silodosiin neid lihaseid, misjärel urineerimine on kergem ja eesnäärme healoomulise hüperplaasia sümptomid leevenevad.
English: Silodyx is used to treat the symptoms of benign prostatic hyperplasia (BPH, an enlarged prostate gland) in adults.
Estonian: Silodyxi kasutatakse eesnäärme healoomulise hüperplaasia (suurenemise) sümptomite raviks täiskasvanutel.
English: Silodyx has been compared with placebo (a dummy treatment) in three main studies involving over 1,800 men with BPH.
Estonian: Silodyxi uuriti kolmes põhiuuringus, kus osales enam kui 1800 eesnäärme healoomulise hüperplaasiaga meest.
English: IPSS is a rating of the patient's symptoms such as the inability to empty the bladder, and the urge to urinate repeatedly or to strain while urinating.
Estonian: Rahvusvaheline eesnäärme sümptomite skoor on patsiendi hinnang esinevatele sümptomitele, nagu kusepeetus ja kusepakitsus ning pingutuse vajalikkus urineerimisel.
English: The effects of Silodyx were first tested in experimental models before being studied in humans.
Estonian: Enne inimuuringuid kontrolliti Silodyxi toimet muude katsetega.
English: What benefit has Silodyx shown during the studies?
Estonian: Milles seisneb uuringute põhjal Silodyxi kasulikkus?
English: How is Silodyx used?
Estonian: Kuidas Silodyxi kasutatakse?
English: What is Silodyx used for?
Estonian: Milleks Silodyxi kasutatakse?
English: How does Silodyx work?
Estonian: Kuidas Silodyx toimib?
English: It works by blocking receptors called alpha1A adrenoreceptors in the prostate gland, the bladder and the urethra (the tube that leads from the bladder to the outside of the body).
Estonian: Silodyx blokeerib eesnäärmes, kusepõies ja kusitis (juha, mille kaudu uriin kusepõiest väljutatakse) leiduvad alfa-1Aadrenoretseptorid.
English: How has Silodyx been studied?
Estonian: Kuidas Silodyxi uuriti?
English: Pack size
Estonian: Pakendi Suurus
English: The National Competent Authorities, coordinated by the Reference Member State, shall ensure that the following conditions are fulfilled by the Marketing Authorisation Holders:
Estonian: Riikide pädevad asutused, mida koordineerib viiteliikmesriik, tagavad, et müügiloa hoidjad täidavad järgmised tingimused:
English: The protocol and the timelines of the DUS should be provided to the RMS within one month of the commission decision concluding this referral procedure.
Estonian: Uuringu protokoll ja ajakava tuleb esitada viiteliikmesriigile ühe kuu jooksul alates komisjoni otsusest, millega lõpetatakse käesolev esildismenetlus;
English: • Conduct a drug utilisation study (DUS) to monitor the effectiveness of the risk minimisation measures.
Estonian: • riski minimeerimise meetmete tõhususe jälgimiseks tehakse ravimi kasutamise uuring.
English: • Circulate the DHPC agreed upon with the CHMP, in accordance with the agreed communication plan.
Estonian: • tervishoiutöötajatele saadetakse tervishoiutöötajate teatis, mille sisus lepitakse kokku inimravimite komiteega; teatis saadetakse vastavalt kokkulepitud teavituskavale;
English: • Shorten the PSUR cycle to an annual submission
Estonian: • perioodilise ohutusaruande esitamistsüklit lühendatakse ühele aastale.
English: Packaging
Estonian: Nimetus
English: The full EPAR for Sildenafil ratiopharm can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Sildenafil ratiopharmi kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Sildenafil ratiopahrm EMA/432244/2013
Estonian: Sildenafil ratiopharm EMA/432241/2013
English: The European Commission granted a marketing authorisation valid throughout the European Union for Sildenafil ratiopharm on 23 December 2009.
Estonian: Euroopa Komisjon andis Sildenafil ratiopharmi müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 23. detsembril 2009.
English: For Sildenafil ratiopharm to be effective, sexual stimulation is required.
Estonian: Et Sildenafil ratiopharm oleks efektiivne, on vaja seksuaalset stimulatsiooni.
English: The recommended dose of Sildenafil ratiopharm is 50 mg taken as needed about one hour before sexual activity.
Estonian: Sildenafil ratiopharmi soovitatav annus on 50 mg, mis võetakse vajadusel sisse umbes üks tund enne suguühet.
English: Sildenafil ratiopharm is used to treat adult men with erectile dysfunction (sometimes called impotence), when they cannot get or keep a sufficiently hard penis (erection) for satisfactory sexual activity.
Estonian: Sildenafil ratiopharmi kasutatakse erektsioonihäirete (mida mõnikord nimetatakse impotentsuseks) raviks täiskasvanud meestel, kui nad ei suuda saavutada või säilitada rahuldavaks seksuaaleluks vajalikku peenise jäigastumist (erektsiooni).
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for sildenafil.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: For more information about treatment with sildenafil, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Sildenafil ratiopharmiga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: The Committee recommended that Sildenafil ratiopharm be given marketing authorisation.
Estonian: Komitee soovitas anda Sildenafil ratiopharmi müügiloa.
English: liver function or severely reduced kidney function should start treatment with the 25-mg dose.
Estonian: Maksa talitlushäire või neeru raske talitlushäirega patsiendid peavad alustama ravi 25 mg annusega.
English: Because Sildenafil ratiopharm is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Estonian: Et Sildenafil ratiopharm on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: By blocking the breakdown of cGMP, Sildenafil ratiopharm restores erectile function.
Estonian: cGMP lagundamist blokeerides taastab Sildenafil ratiopharm erektsioonitalitluse.
English: The CHMP concluded that, in accordance with EU requirements, Sildenafil ratiopharm has been shown to have comparable quality and to be bioequivalent to Viagra.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud Sildenafil ratiopharmi võrdväärne kvaliteet ja bioekvivalentsus ravimiga Viagra.
English: Therefore, the CHMP's view was that, as for Viagra, the benefit outweighs the identified risk.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Viagra korral, ületab Sildenafil ratiopharmi kasulikkus sellega kaasnevad riskid.
English: This means that Sildenafil ratiopharm is similar to a ‘reference medicine' already authorised in the European Union (EU) called Viagra.
Estonian: See tähendab, et Sildenafil ratiopharm on sarnane Euroopa Liidus juba müügiloa saanud võrdlusravimiga Viagra.
English: If Sildenafil ratiopharm is taken with food, the onset of activity may be delayed compared with taking Sildenafil ratiopharm without food.
Estonian: Kui Sildenafil ratiopharmi võetakse koos toiduga, võib ravimi toime avalduda hiljem kui ilma toiduta võtmisel.
English: The active ingredient in Sildenafil ratiopharm, sildenafil, belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.
Estonian: Sildenafil ratiopharmi toimeaine sildenafiil kuulub fosfodiesteraas-5 (PDE5) inhibiitorite ravimirühma.
English: This is a summary of the European public assessment report (EPAR) for sildenafil.
Estonian: See on ravimi Sildenafil ratiopharm Euroopa avaliku hindamisaruande kokkuvõte.
English: Other information about sildenafil
Estonian: Muu teave Sildenafil ratiopharmi kohta
English: Because Sildenafil ratiopharm is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Viagra.
Estonian: Et Sildenafil ratiopharm on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati Sildenafil ratiopharmi bioekvivalentsust võrdlusravimiga Viagra.
English: Sildenafil ratiopharm is a ‘generic medicine'.
Estonian: Sildenafil ratiopharm on geneeriline ravim.
English: Sildenafil ratiopharm is a medicine that contains the active substance sildenafil.
Estonian: Sildenafil ratiopharm on ravim, mis sisaldab toimeainena sildenafiili.
English: Sildenafil ratiopahrm sildenafil
Estonian: Sildenafil ratiopharm sildenafiil
English: Why has sildenafil been approved?
Estonian: Miks Sildenafil ratiopharm heaks kiideti?
English: What is sildenafil?
Estonian: Mis on Sildenafil ratiopharm?
English: What are the benefits and risks of sildenafil?
Estonian: Milles seisneb Sildenafil ratiopharmi kasulikkus ja mis riskid ravimiga kaasnevad?
English: How has sildenafil been studied?
Estonian: Kuidas Sildenafil ratiopharmi uuriti?
English: How is sildenafil used?
Estonian: Kuidas Sildenafil ratiopharmi kasutatakse?
English: How does sildenafil work?
Estonian: Kuidas Sildenafil ratiopharm toimib?
English: What is sildenafil used for?
Estonian: Milleks Sildenafil ratiopharmi kasutatakse?
English: Abseamed may not be suitable for you.
Estonian: Abseamed ei pruugi teile sobida.
English: Other medicines and Abseamed
Estonian: Muud ravimid ja Abseamed
English: • Only use Abseamed if it has been stored correctly - see section 5, How to store Abseamed.
Estonian: • Kasutage Abseamedi ainult juhul, kui seda on õigesti säilitatud (vt lõik 5, Kuidas Abseamedi säilitada).
English: For patients on peritoneal dialysis Abseamed may be given twice a week.
Estonian: Peritoneaalset dialüüsi saavatele patsientidele võib Abseamedi manustada kaks korda nädalas.
English: Abseamed has no or negligible influence on the ability to drive and use machines.
Estonian: Abseamedil ei ole või on ebaoluline toime autojuhtimise ja masinate käsitsemise võimele.
English: Abseamed is a sterile but unpreserved product and is for single use only.
Estonian: Abseamed on steriilne, kuid säilitusaineteta ravim ning on mõeldud ainult ühekordseks kasutamiseks.
English: Abseamed should not be used and discarded - if the liquid is coloured or you can see particles floating in it, - if the seal is broken, - if you know, or think that it may have been accidentally frozen, or - if there has been a refrigerator failure.
Estonian: Abseamedi ei tohi kasutada ja see tuleb hävitada: - kui vedelik on hägune või kui selles on näha hõljuvaid osakesi, - kui pakendi kinnitus on katkine, - kui on teada või arvata, et lahus on kogemata külmutatud, või - kui külmiku töös on toimunud rike.
English: Iron supplements and other blood stimulants may increase the effectiveness of Abseamed.
Estonian: Rauda sisaldavad toidulisandid ja muud vere stimulandid võivad Abseamedi efektiivsust suurendada.
English: If signs and symptoms suggestive of these reactions appear, Abseamed should be withdrawn immediately and an alternative treatment considered.
Estonian: Kui ilmnevad nendele reaktsioonidele viitavad tunnused ja sümptomid, peab Abseamedi kasutamise kohe lõpetama ja kaaluma alternatiivse ravimi kasutamist.
English: Your doctor has carried out blood tests and decided you need Abseamed.
Estonian: Teie arst on teostanud vereanalüüse ja otsustanud, et te vajate Abseamedi.
English: If you are a cancer patient be aware that products that stimulate red blood cell production (like Abseamed) may act as a growth factor and therefore in theory may affect the progression of your cancer.
Estonian: Kui te olete vähihaige, pidage meeles, et punaste vereliblede tootmist stimuleerivad tooted (nagu Abseamed) võivad toimida kasvufaktorina ja seega teoreetiliselt mõjutada teie vähi progressiooni.
English: If you use more Abseamed than you should
Estonian: Kui te kasutate Abseamedi rohkem kui ette nähtud
English: Because Abseamed stimulates the production of red blood cells, doctors can take more blood from these people.
Estonian: Kuna Abseamed stimuleerib punaste vereliblede tootmist, võivad arstid neilt inimestelt rohkem verd võtta.
English: The dose of Abseamed you receive is based on your body weight in kilograms.
Estonian: Teile manustatav Abseamedi annus sõltub teie kehakaalust kilogrammides.
English: In those situations in which the physician determines that a patient or caregiver can safely and effectively administer Abseamed subcutaneously themselves, instruction as to the proper dosage and administration should be provided.
Estonian: Olukordades, kus arst otsustab, et patsient ise või hooldaja võib ohutult ja efektiivselt Abseamedi subkutaanselt manustada, tuleb nõustada õige annuse ja manustamise juhiste osas.
English: If you forget to use Abseamed
Estonian: Kui te unustate Abseamedi kasutada
English: • You may take Abseamed out of the refrigerator and keep it at room temperature (up to 25°C) for no longer than 3 days.
Estonian: • Te võite Abseamedi külmkapist välja võtta ja hoida seda toatemperatuuril (kuni 25°C) mitte kauem kui 3 päeva.
English: During the maintenance phase, Abseamed can be administered either 3 times per week, and in the case of subcutaneous administration, once weekly or once every 2 weeks.
Estonian: Säilitusfaasi ajal manustatakse Abseamedi kas 3 korda nädalas või subkutaanse manustamise korral kord nädalas või üks kord iga 2 nädala järel.
English: Treatment with Abseamed has to be initiated under the supervision of physicians experienced in the management of patients with the above indications.
Estonian: Abseamed-ravi peab alustama ülalnimetatud näidustustega patsientide ravimises kogenud arstide järelevalve all.
English: If Abseamed is injected under the skin (subcutaneously), the amount injected is not normally more than one millilitre (1 mL) in a single injection.
Estonian: Kui Abseamedi süstitakse naha alla (subkutaanselt), ei ole süstitav kogus tavaliselt suurem kui üks milliliiter (1 ml) ühe süsti kohta.
English: Abseamed should not be used:
Estonian: Abseamedi ei tohi kasutada:
English: • Your doctor may initiate treatment with Abseamed if your haemoglobin is 10 g/dL or less.
Estonian: • Teie arst võib alustada Abseamed-ravi, kui teie hemoglobiinisisaldus on 10 g/dl või alla selle.
English: • if you have been diagnosed with Pure Red Cell Aplasia (the bone marrow cannot produce enough red blood cells) after previous treatment with any product that stimulates red blood cell production (including Abseamed).
Estonian: • kui teil on diagnoositud isoleeritud erütrotsütaarne aplaasia (luuüdi ei tooda piisavalt vere punaliblesid) pärast eelnevat ravi mis tahes tootega, mis stimuleerib punaste vereliblede tootmist (sh Abseamed).
English: When treatment starts, Abseamed is usually injected by a medical professional or a nurse.
Estonian: Ravi alustamisel süstib Abseamedi tavaliselt meditsiinitöötaja või meditsiiniõde.
English: What you need to know before you use Abseamed
Estonian: Mida on vaja teada enne Abseamedi kasutamist
English: • Always use Abseamed exactly as instructed by your doctor or nurse.
Estonian: • Kasutage Abseamedi alati täpselt nii, nagu arst või meditsiiniõde on teile selgitanud.
English: If you visit a hospital, clinic or family doctor, tell them you are having Abseamed treatment.
Estonian: Kui te külastate haiglat, kliinikut või perearsti, rääkige, et te saate Abseamed-ravi.
English: Medice Arzneimittel Pütter GmbH & Co. KG, Kuhloweg 37, D-58638 Iserlohn, Germany
Estonian: KG, Kuhloweg 37, D-58638 Iserlohn, Saksamaa
English: • For adults and children Abseamed is given as an injection either into a vein (intravenously) or a tube that goes into a vein.
Estonian: • Täiskasvanutele ja lastele manustatakse Abseamedi kas veenisisese süstena (intravenoosselt) või süstena veeni viivasse voolikusse.
English: Abseamed is a biosimilar medicinal product.
Estonian: Abseamed on bioloogiliselt sarnane ravimpreparaat.
English: What Abseamed contains
Estonian: Mida Abseamed sisaldab
English: Treatment with Abseamed is divided into two stages - correction and maintenance phase.
Estonian: Abseamed-ravi on kaheastmeline - korrektsioonifaas ja säilitusfaas.
English: Abseamed is provided with or without a needle safety guard and you will be shown how to use this by your doctor or nurse.
Estonian: Abseamedi turustatakse koos nõelakaitsega või ilma ning teie arst või õde näitab teile, kuidas seda kasutada.
English: If you are a patient with chronic renal failure, and particularly if you do not respond properly to Abseamed, your doctor will check your dose of Abseamed because repeatedly increasing your dose of Abseamed if you are not responding to treatment may increase the risk of having a problem of the heart or the blood vessels and could increase risk of myocardial infarction, stroke and death.
Estonian: Kui te olete kroonilise neerupuudulikkusega patsient ja, iseäranis, kui teil puudub hea ravivastus Abseamedile, kontrollib arst teie Abseamedi annust, sest kui teil ravivastus puudub, võib teie Abseamedi annuse korduv suurendamine suurendada südame või veresoonte probleemide tekkeriski ja võib suurendada müokardi infarkti, insuldi ning surma ohtu.
English: “Instructions on how to inject Abseamed yourself” can be found at the end of the package leaflet.
Estonian: „Kuidas Abseamedi endale ise süstida“ on ära toodud pakendi infolehe lõpus.
English: • You may be given iron supplements before and during Abseamed treatment to make it more effective.
Estonian: • Teile võidakse anda enne Abseamedi ravi ja selle vältel rauda sisaldavaid toidulisandeid, et ravi veelgi tõhustada.
English: Your doctor will decide how Abseamed will be injected.
Estonian: Teie arst otsustab, kuidas Abseamedi süstitakse.
English: What Abseamed looks like and contents of the pack
Estonian: Kuidas Abseamed välja näeb ja pakendi sisu
English: Abseamed is prescribed to stimulate your bone marrow to produce more red blood cells.
Estonian: Abseamed kirjutatakse teile välja, et stimuleerida teie luuüdi tootma rohkem punaseid vereliblesid.
English: Abseamed can reduce the need for a blood transfusion.
Estonian: Abseamed võib vähendada vereülekannete vajadust.
English: If you can't take medicines that prevent blood clotting, you must not have Abseamed.
Estonian: Kui te ei saa kasutada verehüüvet takistavaid ravimeid, siis te ei tohi Abseamedi kasutada.
English: • If you are having dialysis treatment when you begin treatment with Abseamed, your dialysis regime may need to be adjusted.
Estonian: • Kui te saate Abseamedi ravi alustades dialüüsi, võib vajalikuks osutuda teie dialüüsi ravirežiimi kohandamine.
English: Some people, depending on why they need Abseamed treatment, may later learn how to inject themselves under the skin: see Instructions on how to inject Abseamed yourself at the end of the leaflet.
Estonian: Mõned inimesed (sõltuvalt sellest, miks nad Abseamedi ravi vajavad) võivad hiljem õppida, kuidas endale ise nahaaluseid süste teha (vt infolehe lõpus olevat lõiku „Kuidas Abseamedi endale ise süstida“).
English: If the patient has developed a severe cutaneous skin reaction such as SJS or TEN due to the use of Abseamed, treatment with Abseamed must not be restarted in this patient at any time.
Estonian: Kui patsiendil on Abseamedi kasutamise tõttu tekkinud raske nahareaktsioon, nagu SJS või TEN, ei tohi ravi Abseamediga sellel patsiendil mitte kunagi uuesti alustada.
English: When this access (via a vein or tube) is not readily available, your doctor may decide that Abseamed should be injected under the skin (subcutaneously).
Estonian: Kui veenisisene või vooliku kaudu manustamine pole võimalik, võib teie arst otsustada, et Abseamedi tuleb süstida naha alla (subkutaanselt).
English: Do not administer Abseamed by intravenous infusion or in conjunction with other medicinal product solutions (please refer to section 6.6 for further information).
Estonian: Ärge manustage Abseamedi intravenoosse infusioonina ega koos teiste ravimilahustega (lisateave vt lõik 6.6).
English: If you are a cancer patient, be aware that use of Abseamed may be associated with shorter survival and a higher death rate in head and neck, and metastatic breast cancer patients who are receiving chemotherapy.
Estonian: Kui te olete vähihaige, pidage meeles, et Abseamedi kasutamine võib olla seotud lühema elulemuse ja suurema letaalsusega pea- ja kaelapiirkonna vähiga ning metastaasidega rinnavähiga patsientidel, kes saavad keemiaravi.
English: Abseamed should be administered after the completion of the blood donation procedure.
Estonian: Abseamedi tuleb manustada pärast vere kogumise lõpetamist.
English: Where intravenous access is not readily available (patients not yet undergoing dialysis and peritoneal dialysis patients) Abseamed may be administered as a subcutaneous injection.
Estonian: Kui intravenoosne manustamistee puudub (patsiendid, kes ei läbi veel dialüüsi, ja peritoneaaldialüüsitavad patsiendid), võib Abseamedi manustada subkutaanselt.
English: Later, your doctor may suggest that you or your caregiver learn how to inject Abseamed under the skin
Estonian: Hiljem võib arst pakkuda teile või teie hooldajale võimalust õppida Abseamedi naha alla (subkutaanselt) süstimist.
English: • Before use, leave the Abseamed syringe to stand until it reaches room temperature.
Estonian: • Enne kasutamist jätke Abseamedi süstel soojenema, kuni vedelik saavutab toatemperatuuri.
English: Abseamed can reduce the need for a blood transfusion in these patients.
Estonian: Abseamed võib neil patsientidel vähendada vereülekande vajadust.
English: Your doctor will help you to decide if Abseamed is suitable for you.
Estonian: Arst aitab teil otsustada, kas Abseamed sobib teile või mitte.
English: If you are taking a medicine called cyclosporin (used e.g. after kidney transplants), your doctor may order blood tests to check the level of cyclosporin while you are taking Abseamed.
Estonian: Kui te võtate tsüklosporiini (kasutatakse nt pärast neerude siirdamist), võib teie arst teha vereproove, et kontrollida tsüklosporiini taset Abseamedi-ravi ajal.
English: • If you do not respond adequately to Abseamed, your doctor will check your dose and will inform you if you need to change doses of Abseamed.
Estonian: • Kui teil puudub piisav ravivastus Abseamedile, kontrollib arst teie Abseamedi annust ning annab teile teada, kas teil on vaja Abseamedi annuseid muuta.
English: Inject the Abseamed solution as you have been shown by your doctor.
Estonian: Süstige Abseamedi lahus, nagu arst on teile ette näidanud.